Get Live Data

George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here. 

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Allergy Thera. Share Price
  4. Allergy Thera. Share Regulatory News

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Allergy Thera. Information

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.85
Bid: 2.80
Ask: 2.90
Change: 0.00 (0.00%)
Spread: 0.10 (3.571%)
Open: 2.85
High: 2.85
Low: 2.85
Prev. Close: 2.85
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

12345678910
Date   Source Headline
25th Apr 20227:00 amRNSAllergy Therapeutics shares data at WAO-BSACI
7th Mar 20227:00 amRNSAllergy Therapeutics at Investor Meet Company
3rd Mar 20227:00 amRNSAllergy Therapeutics plc – Interim Results
1st Mar 20227:00 amRNSAllergy Therapeutics shares positive new data
24th Feb 20224:41 pmRNSSecond Price Monitoring Extn
24th Feb 20224:36 pmRNSPrice Monitoring Extension
24th Feb 20222:06 pmRNSSecond Price Monitoring Extn
24th Feb 20222:01 pmRNSPrice Monitoring Extension
2nd Feb 202211:05 amRNSSecures new revolving credit facility
1st Feb 20222:16 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSFDA clearance of IND application for VLP Peanut
24th Jan 20221:13 pmRNSHolding(s) in Company
13th Jan 20227:00 amRNSHalf Year Trading Update & Notice of Results
5th Jan 20228:47 amRNSTotal Voting Rights
25th Nov 20219:17 amRNSAllergy Therapeutics: Granting of Awards
23rd Nov 202112:54 pmRNSResult of AGM
11th Nov 20217:00 amRNSDirector Dealings
27th Oct 20217:00 amRNSCheryl MacDiarmid appointed to Board of Directors
25th Oct 20219:00 amRNSPrice Monitoring Extension
14th Oct 20219:24 amRNSHolding(s) in Company
7th Oct 20214:37 pmRNSAnnual Report and AGM Notification
23rd Sep 20217:00 amRNSPreliminary Results for Year ended 30 June 2021
16th Sep 20217:00 amRNSImmunoBON voted Most Innovative Product of 2021
13th Sep 20217:00 amRNSSecondary endpoints from VLP Peanut 001
9th Sep 20217:00 amRNSAllergy to Present at H.C. Wainwright Conference
7th Sep 20217:00 amRNSAllergy to host KOL webinar on VLP Peanut
3rd Aug 20217:00 amRNSSuccessful primary outcome of VLP Peanut 001
2nd Aug 202110:57 amRNSTotal Voting Rights
14th Jul 20217:00 amRNSTrading update for the year ended 30 June 2021
8th Jul 20217:00 amRNSAGY to present key scientific findings at EAACI
24th Jun 20217:00 amRNSTrading Update
1st Jun 20213:36 pmRNSTotal Voting Rights
10th May 20212:06 pmRNSSecond Price Monitoring Extn
10th May 20212:00 pmRNSPrice Monitoring Extension
6th May 20217:00 amRNSCompletion of treatment phase in G309 study
30th Apr 20215:47 pmRNSTotal Voting Rights
16th Apr 20217:00 amRNSAppointment of new Group auditors
31st Mar 20218:29 amRNSVesting of Awards under Long Term Incentive Plan
26th Mar 20214:39 pmRNSPledge of Shares
11th Mar 202112:13 pmRNSPledge of Shares
10th Mar 20214:40 pmRNSSecond Price Monitoring Extn
10th Mar 20214:35 pmRNSPrice Monitoring Extension
10th Mar 20212:05 pmRNSSecond Price Monitoring Extn
10th Mar 20212:00 pmRNSPrice Monitoring Extension
8th Mar 20217:00 amRNSAGY to Present at H.C. Wainwright Conference
3rd Mar 20217:00 amRNSInterim Results for six months ended 31 Dec 2020
15th Jan 20217:00 amRNSBlock Listing Return and Total Voting Rights
13th Jan 20217:00 amRNSHalf Year Trading Update 2021 & Notice of Results
8th Jan 20214:41 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.